期刊文献+

临床药师参与1例耐多药铜绿假单胞菌感染患者会诊的药学实践 被引量:3

Clinical Pharmacists' Involvement in Pharmacy Consultation for One Case of Multidrug-resistant Pseudomonas aeruginosa Infection
下载PDF
导出
摘要 目的:为耐多药铜绿假单胞菌感染患者的抗菌药物合理应用提供参考。方法:分析1例耐多药铜绿假单胞菌感染患者的抗感染方案,结合痰培养、药敏试验结果及抗菌药物的药理学特性,临床药师建议用药方案为亚胺培南/西司他丁钠(1 g、ivgtt、q6h)+盐酸莫西沙星氯化钠注射液(0.4 g、ivgtt、qd)二联抗感染治疗。结果:患者的感染症状得到有效控制。结论:临床药师参与耐多药铜绿假单胞菌感染患者的临床会诊,可帮助临床医师解决药物治疗难题,提高治疗水平,保证药物治疗的有效、安全、经济和合理。 OBJECTIVE:To provide reference for rational use of antibiotics in patients with multidrug-resistant Pseudomonas aeruginosa infection. METHODS:By analyzing the anti-infective program for one case of multidrug-resistant Pseudomonas aeruginosa infection and based on sputum culture,antimicrobial susceptibility test results and the pharmacological properties of antibiotics,clinical pharmacist recommended using imipenem/cilastatin sodium(1 g,ivgtt,q6h)plus Moxifloxacin hydrochloride and sodium chloride injection(0.4 g,ivgtt,qd)as anti-infection therapy. RESULTS:Patients' infection was under effective control. CONCLUSIONS:The clinical pharmacists' involvement in clinical consultation for patient with multi-drug resistant Pseudomonas aeruginosa infection can help clinicians solve the medication problem,improve the treatment level and ensure effective,safe,economic and reasonable medication.
出处 《中国医院用药评价与分析》 2014年第8期743-745,共3页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 铜绿假单胞菌 多药耐药菌 药学会诊 Pseudomonas aeruginosa Multidrug-resistant bacteria Pharmacy consultation
  • 相关文献

参考文献9

二级参考文献43

  • 1王继东,周丽珍,宫玲玲,糜祖煌,秦玲.铜绿假单胞菌的多重耐药基因研究[J].中华医院感染学杂志,2006,16(3):241-244. 被引量:77
  • 2王豫平,王慕云,廖致红.多重耐药铜绿假单胞菌感染相关因素分析[J].中华医院感染学杂志,2006,16(9):1059-1060. 被引量:59
  • 3CLSI Performance standards for antimicrobial susceptibility testing[S]. Twenty second Informational supplement M100- S22 2012,32(3).
  • 4European Committee on Antimicrobial susceptibility testing, Breakpoint tables for interpretation of MICs and zone diame- ters[S]. Version 2, 2012, valid from 2012-01-01.
  • 5Bush K. Alarming β-lactamase mediated resistance in multi- drug-resistant Enterobacteraceae[J]. Curr Opinion Microbi- oh 2010, 13(5): 558-564.
  • 6Nordmann P, Dortet L, Poirel L. Carbepenem resistance in Enterobacteriaceae: here is the storm! [J]. Trends Mol Med, 2012, 18(6): 263-271.
  • 7Hu FP, Chen SD, Xu XG, et al. Emergence of carbapenem resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012,61 (Ptl) : 132-136.
  • 8Yang Q, Wang H, Sun H, et al. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased suseep tibility to carbapenems: results from large hospital-based sur veillance studies in China[J]. Antimicrob Agents Chemoth er, 2010, 54(1):573-577.
  • 9Chen SD, Hu FP, Xu XG, et al. High prevalence of KPC-2 carbapenemase coupled with CTX-M-type extended-spectrum 13-1actamase in carbapenem-resistant Klebsiella pneumoniae in a teaching hospital in China[J]. Antimierob Agents Che- mother, 2011, 55(5) :2493-2444.
  • 10Hawser SP, Bouchillon SK, Lascols C, et al. Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infec- tions and molecular characterization of ertapenem-resistant i- solates[J]. Antimicrob Agents Chemother, 2011, 55 (8) : 3917-3921.

共引文献511

同被引文献35

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部